Christina S McCrae1, Ashley F Curtis1, Jacob M Williams2, Natalie D Dautovich3, Joseph P H McNamara4, Ashley Stripling5,6, Joseph M Dzierzewski3, Richard B Berry7, Karin M McCoy8, Michael Marsiske9. 1. Department of Psychiatry, University of Missouri-Columbia , Columbia, MO. 2. TIRR Memorial Hermann , Houston, TX. 3. Psychology Department, Virginia Commonwealth University , Richmond, VA. 4. Department of Psychiatry, University of Florida , Gainesville, FL. 5. College of Psychology, Nova Southeastern University , Fort Lauderdale, Florida. 6. Department of Psychiatry, Geisel School of Medicine, Dartmouth College , Hanover, NH. 7. College of Medicine, University of Florida , Gainesville, FL. 8. Neuropsychology Service, South Texas Veterans Health Care System , San Antonio, TX. 9. Department of Clinical and Health Psychology, University of Florida , Gainesville, FL.
Abstract
OBJECTIVE:Behavioral treatments for insomnia improve sleep in older adults, but research documenting their effects on cognitive performance is mixed. We explored whether a brief behavioral treatment for insomnia (BBTi) impacts daily associations between sleep parameters and next day cognition. METHODS:Sixty-two older adults (Mage = 69.45 years, SD = 7.71) with insomnia completed either 4 weeks of BBTi or self-monitoring control (SMC). At baseline, post-treatment, and 3 month follow-up, participants completed 14 days of diaries measuring sleep onset latency (SOL), wake after sleep onset (WASO), total sleep time (TST), and sleep efficiency (SE), as well as daily cognitive tests measuring processing speed (i.e., symbol digit modalities test, SDMT), and reasoning (i.e., letter series). At each time period, associations between sleep parameters and daily cognition, controlling for age, education, insomnia duration, use of sleep medications, and depression (i.e., Beck Depression Inventory-2nd Edition scores), were examined through multilevel modeling. RESULTS: At post-treatment, we observed an interactive fixed effect of treatment condition (i.e., BBTi/SMC) and TST on daily SDMT and letter series performance. For BBTi, longer TST was associated with better letter series performance, and did not predict SDMT performance. For SMC, longer TST was associated with worse SDMT, and was not associated with letter series performance. Greater WASO (regardless of group) was associated with better SDMT performance at post-treatment. Associations were not maintained at follow-up. CONCLUSIONS: Sleep duration may play an important role in BBTi-related improvements in daily higher order cognition. Maintenance of these associations may be facilitated by booster sessions following post-treatment. CLINICAL TRIAL IDENTIFIER: NCT02967185.
RCT Entities:
OBJECTIVE: Behavioral treatments for insomnia improve sleep in older adults, but research documenting their effects on cognitive performance is mixed. We explored whether a brief behavioral treatment for insomnia (BBTi) impacts daily associations between sleep parameters and next day cognition. METHODS: Sixty-two older adults (Mage = 69.45 years, SD = 7.71) with insomnia completed either 4 weeks of BBTi or self-monitoring control (SMC). At baseline, post-treatment, and 3 month follow-up, participants completed 14 days of diaries measuring sleep onset latency (SOL), wake after sleep onset (WASO), total sleep time (TST), and sleep efficiency (SE), as well as daily cognitive tests measuring processing speed (i.e., symbol digit modalities test, SDMT), and reasoning (i.e., letter series). At each time period, associations between sleep parameters and daily cognition, controlling for age, education, insomnia duration, use of sleep medications, and depression (i.e., Beck Depression Inventory-2nd Edition scores), were examined through multilevel modeling. RESULTS: At post-treatment, we observed an interactive fixed effect of treatment condition (i.e., BBTi/SMC) and TST on daily SDMT and letter series performance. For BBTi, longer TST was associated with better letter series performance, and did not predict SDMT performance. For SMC, longer TST was associated with worse SDMT, and was not associated with letter series performance. Greater WASO (regardless of group) was associated with better SDMT performance at post-treatment. Associations were not maintained at follow-up. CONCLUSIONS: Sleep duration may play an important role in BBTi-related improvements in daily higher order cognition. Maintenance of these associations may be facilitated by booster sessions following post-treatment. CLINICAL TRIAL IDENTIFIER: NCT02967185.
Authors: Jens P Nilsson; Marie Söderström; Andreas U Karlsson; Mats Lekander; Torbjörn Akerstedt; Nina Erixon Lindroth; John Axelsson Journal: J Sleep Res Date: 2005-03 Impact factor: 3.981
Authors: Kristine A Wilckens; Martica H Hall; Kirk I Erickson; Anne Germain; Vishwajit L Nimgaonkar; Timothy H Monk; Daniel J Buysse Journal: Sleep Med Date: 2016-10-21 Impact factor: 3.492
Authors: Daniel J Buysse; Anne Germain; Douglas E Moul; Peter L Franzen; Laurie K Brar; Mary E Fletcher; Amy Begley; Patricia R Houck; Sati Mazumdar; Charles F Reynolds; Timothy H Monk Journal: Arch Intern Med Date: 2011-01-24
Authors: Alberto R Ramos; Chuanhui Dong; Mitchell S V Elkind; Bernadette Boden-Albala; Ralph L Sacco; Tatjana Rundek; Clinton B Wright Journal: J Clin Sleep Med Date: 2013-07-15 Impact factor: 4.062
Authors: Lee M Ritterband; Elaine T Bailey; Frances P Thorndike; Holly R Lord; Leah Farrell-Carnahan; Lora D Baum Journal: Psychooncology Date: 2011-04-29 Impact factor: 3.894
Authors: Kristine A Wilckens; Martica H Hall; Robert D Nebes; Timothy H Monk; Daniel J Buysse Journal: Behav Sleep Med Date: 2015-08-31 Impact factor: 2.964
Authors: Robert D Nebes; Daniel J Buysse; Edythe M Halligan; Patricia R Houck; Timothy H Monk Journal: J Gerontol B Psychol Sci Soc Sci Date: 2009-02-09 Impact factor: 4.077